Systemic treatment for moderate to severe psoriasis: Estimates of failure rates and direct medical costs in a north‐eastern US managed care plan

Abstract

Treatment of moderate to severe psoriasis with traditional systemic agents or phototherapy is associated with a high likelihood of treatment failure and a considerable economic burden.